Poliomyelitis News
-
(Viral) Vaccine Manufacturing
It is well accepted that vaccination is one of the most effective ways to prevent diseases. A vaccine helps the body’s immune system to recognize and fight pathogens like bacteria or viruses, which then keeps humans safe from the diseases they cause. Vaccines protect against a range of diseases, including measles, polio, diphtheria, tetanus, meningitis, influenza and cancer. ...
By Nuvonis
-
AJ Vaccines intend to widen activities in the Middle East Region
AJ Vaccines’ production site-facility in Copenhagen, Denmark has been approved by the Gulf Health Council (GHC) effective 9 November 2020. The approval indicates the vaccine production is at a high standard which will help to secure timely patient access to vaccines in the Gulf Cooperation Council (GCC) countries and wider Middle Eastern region. In recent years, the regulatory requirements ...
-
Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine
International vaccine manufacturer, AJ Vaccines has received WHO prequalification for Picovax®, the first stand-alone dose sparing Inactivated Polio Vaccine (IPV) on 21st April 2020. First deliveries to UN agencies such as UNICEF and PAHO are expected by mid-2020. COPENHAGEN, 22 April 2020 – Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with ...
-
AJ Vaccines will contribute to global polio eradication with its innovative vaccine Picovax®
AJ Vaccines today announced that its adjuvanted IPV vaccine Picovax® has gained marketing approval in Denmark by the Danish Medicines Agency. The approval process was initiated in 2018 following positive results from clinical trials involving almost 3,000 infants. The Danish marketing approval paves the way for WHO prequalification with a view to enable AJ Vaccines to deliver Picovax® ...
-
Micron receives additional funding from the CDC for collaboration on the development of a microneedle patch for IRV-IPV co-administration
ATLANTA, August 27, 2018 – Micron Biomedical, Inc. (Micron) was awarded a new research contract by the Centers for Disease Control and Prevention (CDC) to continue the development of an IRV-IPV microneedle patch and its GMP manufacturing process. This new research contract comes after Micron successfully completed a Phase 1 SBIR grant and a research contract with the CDC for the ...
-
AJ Vaccines expands capacity with a comprehensive reconstruction and renovation of its Polio vaccine production
AJ Vaccines has initiated a total reconstruction and expansion of its existing Polio vaccine production facilities. The new facilities will increase production capacity substantially while simultaneously ensuring compliance with future WHO demands for Polio vaccine production and containment. AJ Vaccines and the company’s owner have decided to initiate a comprehensive and needed upgrade of ...
-
Partners for a new beginning announces full steering committee and Clinton Global Initiative commitments
Former US Secretary of State Madeleine Albright, along with Muhtar Kent, Chairman and CEO of The Coca-Cola Company, and Walter Isaacson, President and CEO of The Aspen Institute, announced today the formation of the Steering Committee and the Clinton Global Initiative (CGI) commitments for Partners for a New Beginning (PNB). Partners for a New Beginning is a non-partisan, non-profit organization ...
-
Combined Federal Campaign of the National Capital Area announces US$67 million goal for people and communities in need
The Combined Federal Campaign of the National Capital Area (CFCNCA) officially kicked off today with a Leadership Conference for more than 600 Federal government employees at the Marriott Renaissance Hotel in Washington, D.C. Campaign leaders announced the 2010 goal of US$67 million to help people and communities in need. Last year, the CFCNCA community of nearly 150,000 civilian, military and ...
-
More than 20,000 Novartis associates worldwide to volunteer for local causes in Community Partnership Day
Annual volunteer event to commemorate creation of Novartis in 1996 now benefits hundreds of charities in 55 countries More than 20,000 associates worldwide engage in voluntary activities in their communities Novartis event emphasizes ongoing commitment to Corporate Citizenship Thousands of Novartis associates in 55 countries will engage in volunteer activities to benefit people in their ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you